Ultragenyx (RARE) Shares Surge 13% on Groundbreaking Gene Therapy FDA Green Light

Ultragenyx (RARE) stock jumped 13% after FDA approved Fayuvi, the first gene therapy for Sanfilippo syndrome Type A in children. Learn what it means.

The post Ultragenyx (RARE) Shares Surge 13% on Groundbreaking Gene Therapy FDA Green Light appeared first on Blockonomi.